Literature DB >> 23867244

Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis.

Hai-yan Song1, Li Zhang, Jie-lu Pan, Li-li Yang, Guang Ji.   

Abstract

OBJECTIVE: This study aims to evaluate the bioactivity of five components of the traditional Chinese medicine complex prescription Jiangzhi granules against hepatocellular steatosis.
METHODS: The five major components, including protopanaxadiol, tanshinone IIA, emodin, chlorogenic acid, and nuciferine, were extracted from Jiangzhi granules. Their cytotoxicity was assessed to determine the safe dose of each component for HepG2 cells. HepG2 cellular steatosis was induced using 1 mmol/L of free fatty acids (FFAs) for 24 h, and then treated with each component at high, intermediate, and low doses (500, 50, and 5 μmol/L), respectively for another 24 h. The effects on HepG2 steatosis were observed directly under optical phase microscopy, or through oil red O staining and Nile red assays. In addition, the levels of reactive oxygen species (ROS) in the steatotic HepG2 cells with and without high-dose protopanaxadiol treatment were measured using fluorescent dye 2',7'-dichlorodihydrofluorescein diacetate staining.
RESULTS: No obvious cytotoxicity was observed in the HepG2 cells incubated with each of the five components at up to 500 μmol/L. At 24 h after incubation with FFAs, the HepG2 cells swelled and many lipid droplets accumulated. The lipid content was attenuated after 24 h of incubation with protopanaxadiol, tanshinone IIA, and emodin at 500 or 50 μmol/L (P < 0.05), especially with 500 μmol/L protopanaxadiol (P < 0.01). In addition, the ROS level was elevated in steatotic cells, but decreased after intervention with 500 μmol/L protopanaxadiol (P < 0.05).
CONCLUSION: Protopanaxadiol, tanshinone IIA, and emodin alleviate hepatocellular steatosis in a dose-dependent manner, and oxidative stress regulation may partially contribute to the effects of protopanaxadiol.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23867244     DOI: 10.3736/jintegrmed2013034

Source DB:  PubMed          Journal:  J Integr Med


  15 in total

1.  Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model.

Authors:  Chen Ling; Yuan Wang; Yuanhui Zhang; Anila Ejjigani; Zifei Yin; Yuan Lu; Lina Wang; Meng Wang; Jun Li; Zhongbo Hu; George V Aslanidi; Li Zhong; Guangping Gao; Arun Srivastava; Changquan Ling
Journal:  Hum Gene Ther       Date:  2014-12       Impact factor: 5.695

2.  Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease.

Authors:  Weihan Zhao; Lijuan Liu; Yunliang Wang; Tangyou Mao; Junxiang Li
Journal:  Exp Ther Med       Date:  2015-11-09       Impact factor: 2.447

3.  Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.

Authors:  Yang Liu; Haiyan Song; Lei Wang; Hanchen Xu; Xiangbing Shu; Li Zhang; Ying Li; Dongfei Li; Guang Ji
Journal:  J Transl Med       Date:  2014-11-19       Impact factor: 5.531

4.  Ginsenoside Rg1 attenuates ultraviolet B-induced glucocortisides resistance in keratinocytes via Nrf2/HDAC2 signalling.

Authors:  Jun Li; Dong Liu; Jinfeng Wu; Daniel Zhang; Binbin Cheng; Yani Zhang; Zifei Yin; Yuan Wang; Juan Du; Changquan Ling
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

Review 5.  A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.

Authors:  Wei-Fan Hsu; Lee-Yan Sheen; Hung-Jen Lin; Hen-Hong Chang
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-31       Impact factor: 2.629

6.  An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway.

Authors:  Tian-Hong Xie; Jun-Xiang Li; Tang-You Mao; Yi Guo; Chen Chen; Ya-Fei Han; Xiang Tan; Run-Hua Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-07       Impact factor: 2.629

7.  Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury.

Authors:  Yi-Yuan Zheng; Miao Wang; Xiang-Bing Shu; Pei-Yong Zheng; Guang Ji
Journal:  World J Gastroenterol       Date:  2018-03-07       Impact factor: 5.742

Review 8.  Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine.

Authors:  Chien-Shan Cheng; Zhiyu Wang; Jianping Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-13       Impact factor: 2.629

9.  The efficacy and safety of traditional chinese medicine (jiang zhi granule) for nonalcoholic Fatty liver: a multicenter, randomized, placebo-controlled study.

Authors:  Jielu Pan; Miao Wang; Haiyan Song; Lin Wang; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-04       Impact factor: 2.629

10.  Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.

Authors:  Li Zhang; Jiaoya Xu; Haiyan Song; Zemin Yao; Guang Ji
Journal:  J Transl Med       Date:  2014-08-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.